Performance on Clinical Trials

At St George’s we are constantly working towards improving outcomes for our patients and improving the health and well being of the people who use our services and their families, friends and carers. Central to this is our commitment to research.

Research Performance

We publish information on two key indicators: our efficiency in getting clinical trials up and running at St George’s, and our effectiveness at recruiting patients to clinical trials.

Each Quarter we will publish information about how we performed in clinical trials:

  • Initiating Clinical Research: this shows how quickly we get clinical trials up and running. The National Institute of Health Research (NIHR – which is the research arm of the NHS) expects this to happen within 70 days from request to open a trial until the recruitment of the first patient.  It is not possible to reach 100% on this measure as some trials, e.g. rare diseases, only applies to a few patients every year. However, we are committed to a steady improvement on each report
  • Delivering Clinical research: this shows if we recruit the number of patients to a specific trial that we have agreed to.

The full data list and explanations are available below.

Initiating Research

There is a new national approval system that took effect on 1st April 2016 – so we are still working with these changes

Initiation 17-18 Q1

Initiation 16-17 Q4

 

 

Delivering Research

Relationships between St George’s researchers and commercial bodies such as pharmaceutical companies are important. Clinical Research Trials are away that our patients have access to new drugs and treatments – without any cost to the NHS. Getting a drug approved in the Clinical Guideline produced by NICE can take time after the completion of any research on that drug – so these trials often offer treatment much earlier than it would be available on the NHS.

The report has changed in the last year (from 1st April 2016), only looking at trials that closed to recruitment in the last 12 months (as opposed to trials that were closed but still had patient follow-up visits).

Delivery 17-18 Q1

Delivery 16-17 Q4